{
    "clinical_study": {
        "@rank": "105746", 
        "arm_group": [
            {
                "arm_group_label": "Episodic migraineurs", 
                "description": "Those with migraines >2 and < 12 times per month."
            }, 
            {
                "arm_group_label": "Chronic migraineurs", 
                "description": "Those with migraines greater than 14 days per month."
            }, 
            {
                "arm_group_label": "Controls", 
                "description": "Those without headaches other than occasional hangover, cold, flu headaches."
            }
        ], 
        "biospec_descr": {
            "textblock": "serum"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This research is being done to look at the association between migraine and obesity."
        }, 
        "brief_title": "Migraine and Body Composition", 
        "condition": [
            "Migraine With and Without Aura", 
            "Chronic Migraine", 
            "Healthy Controls"
        ], 
        "condition_browse": {
            "mesh_term": "Migraine Disorders"
        }, 
        "detailed_description": {
            "textblock": "Research into the role of inflammatory markers and other obesity related proteins and\n      chemicals may  help us understand migraine and lead to new treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premenopausal women (18-55 years)\n\n          -  Normal weight (BMI = 18.5 - 24.9) or obese (BMI \u2265 30)\n\n          -  Diagnosis of episodic or chronic migraine or pain free control\n\n        Exclusion Criteria:\n\n          -  Evidence of pain disorder other than migraine (e.g. irritable bowel    syndrome)\n\n          -  Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism)\n\n          -  Illnesses that may affect adipokine levels (e.g. diabetes)\n\n          -  Clinically relevant abnormal glucose/cholesterol levels\n\n          -  Pregnant women\n\n          -  Potential participants who are unable to undergo MRI based on standard screening\n             questionnaire (those with brain aneurysm or surgical clips, certain types of\n             artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye\n             implants, blood vessel coil,  recently placed artificial joints, certain types of\n             vascular stents, history of bullets, pellets, BBs, history of any implanted metal or\n             device or who have worked with sheet metal in the past)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Premenopausal Caucasian women ages 18-55 years with or without migraine."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720862", 
            "org_study_id": "NA_00051683"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "migraine", 
            "episodic migraine", 
            "chronic migraine", 
            "obesity", 
            "non-obese"
        ], 
        "lastchanged_date": "November 1, 2012", 
        "location": {
            "contact": {
                "email": "lpeterlin@jhmi.edu", 
                "last_name": "Barbara L Peterlin, D.O.", 
                "phone": "410-550-9550"
            }, 
            "contact_backup": {
                "email": "lwhite@jhmi.edu", 
                "last_name": "Linda W White, CRNP", 
                "phone": "410-550-4418"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21224"
                }, 
                "name": "The Johns Hopkins Bayview Headache Center"
            }, 
            "investigator": {
                "last_name": "Barbara L Peterlin, DO", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Migraine and Body Composition", 
        "overall_contact": {
            "email": "lpeterlin@jhmi.edu", 
            "last_name": "Barbara L Peterlin, D.O.", 
            "phone": "410-550-9550"
        }, 
        "overall_contact_backup": {
            "email": "lwhite@jhmi.edu", 
            "last_name": "Linda W White, CRNP", 
            "phone": "410-550-4418"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Barbara L Peterlin, DO", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency.", 
            "measure": "association between migraine and obesity - evaluate serum adipokine levels", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720862"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Drs Barbara Peterlin", 
            "investigator_title": "Director of Headache Research, Johns Hopkins Bayview", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The second aim of the proposed research is to evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT),in the same clinical cohort of migraineurs to determine if regional adipose tissue differences exist between: (1) episodic migraineurs, (2) chronic migraineurs and (3) controls, thus contributing to the migraine-obesity relationship.", 
            "measure": "association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT)", 
            "safety_issue": "No", 
            "time_frame": "five years"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}